Insurance: Corporate & Transactional

Our corporate and transactional work in the Insurance sector includes M&A, complex reinsurance transactions, insurance company (and insurance brokerage) formation and redomestications, joint ventures, corporate reorganization transactions, InsureTech transactions and a wide range of third party and affiliate service, agency, administrative and other agreements relating to the operation of our Insurance sector clients’ businesses. 

Our global Insurance M&A team is consistently recognized for our market-leading position in  M&A transactions by deal count and for our particular skill with middle market M&A in both the U.S. and UK. Our Insurance M&A team provides deep sector knowledge for insurance industry transactions with team members having decades of experience representing insurance industry clients and significant regulatory experience.

Our Insurance M&A team’s experience ranges from simple acquisitions of shell insurers, to complex, multi-layered acquisitions requiring extensive pre-sale transactions, such as reinsurance of unwanted blocks of business, restructurings, and demutualizations. We also have significant experience with insurance agency and brokerage acquisitions. Our regular involvement in competitive auctions and our experience in acting on both sell-side and buy-side deals gives us a well-rounded, commercial perspective. 

Dedicated Insurance M&A Practice

We regularly advise leading insurance, reinsurance and insurance intermediary clients in both the general/property and casualty and life sectors on strategic M&A, joint venture and corporate structuring transactions, including mergers, share acquisitions and disposals, acquisitions and disposals of blocks of business, renewal rights transactions, and a variety of transactions to release trapped capital. Clients include insurance and reinsurance companies, Lloyd’s syndicates and managing agents, brokers and distributors, and legacy acquirers. We have a leading practice in the UK transferring legacy business through Part VII transfer schemes and regularly advise on share sales and acquisitions in the legacy sector.  Many of our transactions are cross-border in nature and our industry specialists regularly collaborate across our global platform to handle country specific issues.  Our Insurance M&A team also leverages off the strength in other areas of our practice such as Tax, Data Privacy/Security, Employment & Labor, and Employee Benefits so that the full depth of our firm’s experience is brought to bear where relevant for insurance industry transactions. 

Strategic Alternatives & Corporate Reorganizations

We have guided large, multi-national insurance companies through all manner of complex transformations. We manage these projects holistically, addressing the multi-disciplinary considerations each project raises, such as issues relating to cross-border regulations, tax, IT systems, employment, financing/investments, IP and vendor/commercial contracts.

Insurance Regulatory Filings and Approvals

Because our Insurance Team includes Insurance Regulatory experts, we incorporate state and federal regulatory considerations into deal structures and then shepherd them smoothly through the regulatory approval process.  Our regulatory experts (which include a former insurance regulator) have substantial experience obtaining insurance regulatory approvals in all jurisdictions, including those requiring full administrative hearings. We routinely handle insurance company changes in control (Form A) and associated filings (affiliate and material transactions and market share increases) in transactions ranging from simple shell acquisitions to complex, multi-jurisdictional mergers and acquisitions. We appreciate the unique approach required for regulatory approvals involving private equity deals, transactions requiring multi-jurisdictional approvals, and those involving multiple regulated industries, such as banking-insurance mergers.

Additional Insurance Corporate and Transactional Experience

We regularly advise on complex reinsurance arrangements, including reinsurance program design and implementation. We also draft and negotiate affiliate and material agreements for our insurance clients, ensuring they comply with insurance regulatory requirements and, where necessary, assisting with regulatory filings and approvals.  Our work in this area includes agreements between insurers and their affiliates (such as cost-sharing, tax allocation, reinsurance and pooling agreements), as well as extraordinary dividends, surplus note and other financing transactions, and distribution agreements of various types (agency, MGA/MGU and others).

Discover our latest News & Insights

Awards
Sep 28, 2022

Legal 500 UK 2023

Insights
Mar 02, 2022

Corbin & King: Denial of Access clause and Composite policy cover for COVID-19

The Commercial Court has found in Corbin & King Ltd v Axa Insurance UK Plc that a Non-Damage Denial of Access (“NDDA”) clause responds to COVID-19 business interruption losses.  Further, that where the policy provides cover by reference to the Insureds’ “business” where access to its “premises” was restricted, that the insured would be entitled to claim the sub-limit of cover in respect of each premises, for each lockdown or restriction.  This decision, if upheld by appellate courts, could materially increase some insurers’ exposure to COVID-19 business interruption losses if they have underwritten comparable NDDA covers.
Insights
Feb 25, 2022

Is COVID-19 a Catastrophe?

Awards
October 5, 2021

Legal 500 UK 2022

Discover our latest News & Insights

Awards
Sep 28, 2022
Legal 500 UK 2023
Insights
Mar 02, 2022
Corbin & King: Denial of Access clause and Composite policy cover for COVID-19
The Commercial Court has found in Corbin & King Ltd v Axa Insurance UK Plc that a Non-Damage Denial of Access (“NDDA”) clause responds to COVID-19 business interruption losses.  Further, that where the policy provides cover by reference to the Insureds’ “business” where access to its “premises” was restricted, that the insured would be entitled to claim the sub-limit of cover in respect of each premises, for each lockdown or restriction.  This decision, if upheld by appellate courts, could materially increase some insurers’ exposure to COVID-19 business interruption losses if they have underwritten comparable NDDA covers.
Insights
Feb 25, 2022
Is COVID-19 a Catastrophe?
Awards
November 4, 2021
U.S. News - Best Lawyers® 'Best Law Firms' 2022
Awards
October 5, 2021
Legal 500 UK 2022
Insights
Apr 09, 2020
London market impact of U.S. COVID-19 BI law challenge
Insights
Apr 01, 2020
Coronavirus/COVID-19 UK Quick Guide – what insurance cover could be impacted?
Insights
Mar 26, 2020
Must reinsurers follow their cedants’ COVID-19 related claim settlements?
Insights
Mar 09, 2020
Is COVID-19 one "event": reinsurance aggregation

Meet our sector leaders

Gerry Quirk

Gerry Quirk

Partner, London

+44 (0) 20 3400 3243
Adam Bogdanor
+44 (0) 20 3400 4808
Gerry Quirk

Gerry Quirk

Partner, London

+44 (0) 20 3400 3243
Adam Bogdanor
+44 (0) 20 3400 4808